Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.9 USD | +11.11% | +49.91% | -6.29% |
Jun. 07 | HC Wainwright Adjusts Price Target on Replimune to $17 From $12, Maintains Buy Rating | MT |
Jun. 06 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.29% | 485M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Transcript : Replimune Group, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 07